CrushSCI.com
116.2Average days
99Median days
53Fastest days
272Longest days
882025 publications

Paper Review Records

All Paper Review Records

11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

155 days

A novel DMTN :: HMGA2 rearrangement drives aberrant reactivation of HMGA2 with profibrotic and type I interferon–suppressive signaling

Authors
Yan Lin; Sujuan Zhou; Mei Yang; Nan Chen; Jintao Xu; Xingping Lang; Fan Yang; Sheng Xiao; Lijun Meng; Shouli Wang; Liying ZhangShow moreShow less
Affiliations
1. Department of Hematology, The First People's Hospital of Changzhou; 2. Third Affiliated Hospital of Soochow University; 3. Advanced Molecular Pathology Institute of Soochow University and SANO; 4. Suzhou Sano Precision Medicine Ltd, SANO Medical Laboratories; 5. Department of Pathology; 6. School of Basic Medical Sciences of Soochow University; 7. Department of Hematology; 8. Affiliated Hospital of Nantong University; 9. The Second Affiliated Hospital of Soochow UniversityShow moreShow less
Source PDF DOI Publisher page
99 days

RecurIndex-derived molecular features associated with total pathological complete response in triple-negative breast cancer: An exploratory prospective cohort study with single-cell transcriptomic contextualization

Authors
Meilin Chen; Xiwen Yan; Qifan Chen; Jiayi Bei; Zheng Pan; Tian Zhang; Weihao Cheng; Lu Xu; Feng Jin; Yan Gao; Zining Jin; Ang ZhengShow moreShow less
Affiliations
1. Beijing Chaoyang Hospital, Capital Medical University, Beijing Chaoyang Hospital; 2. Department of Breast Surgery, The First Hospital of China Medical University; 3. Department of Medical Oncology, The First Hospital of China Medical University; 4. Department of Human Anatomy, School of Basic Medical Sciences, Capital Medical UniversityShow moreShow less
Source PDF DOI Publisher page
92 days

UBE2S promotes gastric cancer progression through RACGAP1 stabilization associated with K292-dependent K63-linked ubiquitination

Authors
HeFei Cheng; Ziqing Zhou; Qirun Cheng; Ziqi SuiShow moreShow less
Affiliations
1. Department of Gastroenterology, The First People’s Hospital of Linping District; 2. Department of Gastroenterology, The Second Affiliated Hospital of Zhejiang Chinese Medical University; 3. Department of Gastroenterology, Zhejiang HospitalShow moreShow less
Source PDF DOI Publisher page
111 days

ARHGAP40 suppresses clear cell renal cell carcinoma progression and is associated with altered glutamine-related metabolism and redox balance

Authors
Na You; Xiaoxia Wang; Caizhu Wang; Long Ma; Yanli Lyu; Han Liu; Fan Yang; Jiandong Wang; Longjiang Zhang; Jufang WangShow moreShow less
Affiliations
1. School of Biology and Biological Engineering, South China University of Technology; 2. Guangzhou Huayin Medical Laboratory Center Co, Ltd; 3. Guangzhou Huayin Health Group Co., Ltd; 4. Department of Pathology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University; 5. Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University; 6. School of Life Sciences, Jiangsu Key Laboratory for Molecular and Medical Biotechnology, Nanjing Normal UniversityShow moreShow less
Source PDF DOI Publisher page
178 days

Inhibition of WNT signaling sensitizes CRC cells to anti-tumor effects of retinoids: basis for new drug combinations in oncology

Authors
Victoria O. Hunsu; Caroline O. B. Facey; Lynn M. Opdenaker; Bruce M. BomanShow moreShow less
Affiliations
1. Cawley Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute; 2. Department of Biological Sciences, University of Delaware; 3. Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson UniversityShow moreShow less
Source PDF DOI Publisher page
108 days

Elevated miR-103b in exosomes derived from brain-metastatic triple-negative breast cancer cells remodels the brain pre-metastatic niche (PMN)

Authors
Li Zhou; Jin Ke; Shanlan Zhang; Sufang Xiao; Hui Zhang; Shan Liu; Li Liu; Mingan Liu; Zuohua Lu; Songguo ZhengShow moreShow less
Affiliations
1. Department of Oncology, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; 2. Department of Clinical Laboratory, Pudong Gongli Hospital, Shanghai University of Medicine & Health Sciences; 3. Department of Immunology, The School of Cell & Gene Therapy, Songjiang Research Institute and Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; 4. State Key Lab of Innovative Immune Therapy, Shanghai Jiao Tong UniversityShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does CANCER BIOLOGY & THERAPY take to review a manuscript?

As of 2026-11-19, CrushSCI has 11 complete review records for CANCER BIOLOGY & THERAPY. The fastest paper went from submission to acceptance in 53 days (DNA polymerase theta (Polθ): a novel candidate for targeted cancer therapy, received 2026-05-18, accepted 2026-07-10); the slowest took 272 days. The average is 116.2 days and the median is 99 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.